Peer review reports
From: Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma
Original Submission |
16 Oct 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
13 Nov 2022 |
Reviewed |
Reviewer Report
|
25 Nov 2022 |
Reviewed |
Reviewer Report
|
12 Dec 2022 |
Author responded |
Author comments - Wenzhi Shen
|
Resubmission - Version 4 |
12 Dec 2022 |
Submitted |
Manuscript version 4
|
17 Dec 2022 |
Author responded |
Author comments - Wenzhi Shen
|
Resubmission - Version 5 |
17 Dec 2022 |
Submitted |
Manuscript version 5
|
3 Jan 2023 |
Reviewed |
Reviewer Report
|
5 Jan 2023 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
9 Jan 2023 |
Editorially accepted |
|
16 Jan 2023 |
Article published |
10.1186/s12885-023-10535-9
|
Learn about peer review